TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
AdAlta Ltd. ( (AU:1AD) ) has issued an update.
AdAlta Ltd. announced the quotation of 153,657,204 ordinary fully paid securities on the Australian Securities Exchange (ASX) as of October 20, 2025. This move is part of previously announced transactions and is expected to enhance the company’s market presence and liquidity, potentially benefiting stakeholders by increasing the accessibility and visibility of its securities.
More about AdAlta Ltd.
AdAlta Ltd. operates in the biotechnology industry, focusing on the development of novel therapeutic products. The company is known for its proprietary i-body technology, which is used to develop treatments for a range of diseases, including fibrosis and cancer.
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$4.61M
See more data about 1AD stock on TipRanks’ Stock Analysis page.